BDH Industries Ltd (BDH) — shareholding pattern, promoter holding, financials and share price
About BDH Industries Ltd (BDH)
BDH Industries Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as BDH and on the BSE under scrip code 524828. Its ISIN is INE278D01018.
Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals [1]
BDH Industries (BDHIL) manufactures a wide range of drug formulations, focusing on antibiotics, anti-inflammatory, and anti-microbial segments. It offers robust Oral Solid Dosages (OSD) technologies.
The company boasts a well-equipped R&D center in Mumbai, dedicated to developing novel drug delivery systems, signaling a commitment to innovation.
Listed peers in Pharmaceuticals: Medico Remedies Ltd, Infinium Pharmachem Ltd, Trident Lifeline Ltd, Everest Organics Ltd, Astonea Labs Ltd, Zenotech Laboratories Ltd.
Valuation & Returns
10 Jul 2026At ₹520 a share on 10 Jul 2026, BDH Industries Ltd (BDH) was valued at a price-to-earnings ratio of 27.67x against an industry P/E of 36.41x and a price-to-book of 4.35x on a book value of ₹119.43 per share as of Mar 2025. Solomo computes return on equity of 15.74% and return on capital employed of 21.87% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 27.67x
- Industry P/E
- 36.41x
- P/B
- 4.35x
- EPS (TTM)
- ₹18.79
- Book value / share
- ₹119.43
- ROE
- 15.74%
- ROCE
- 21.87%
- ROA
- 12.45%
- Debt / equity
- 0.01x
- Dividend yield
- 0.87%
- EBITDA margin
- 16.8%
- 52-week range
- ₹262.9 – ₹528.4
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, BDH Industries Ltd (BDH) reported revenue of ₹96 crore, net profit of ₹11 crore and earnings per share of ₹18.78. That compares with revenue of ₹67 crore and net profit of ₹9 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹29.03 crore and net profit ₹2.88 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 69 | 74 | 86 | 67 | 96 |
| Net profit (₹ cr) | 7 | 8 | 10 | 9 | 11 |
| EPS (₹) | 12.54 | 14.24 | 17.14 | 16.1 | 18.78 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 4.00% | 2.26% | -1.41% | -22.51% |
| Profit growth | 12.45% | 9.31% | 8.69% | -6.08% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 49.7% of BDH Industries Ltd (BDH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.28% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹299 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: INVESTOR EDUCATION AND PROTECTION FUND 7.54%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 49.7% | - | 0.28% | 0% | 50.3% |
| Mar 2026 | 49.7% | 9% | 0.28% | 0% | 50.3% |
| Dec 2025 | 49.7% | - | 0.28% | - | 50.3% |
| Sep 2025 | 49.7% | - | 0.28% | - | 50.3% |
| Jun 2025 | 49.7% | - | 0.28% | - | 50.3% |
| Mar 2025 | 49.66% | - | 0.28% | - | 50.34% |
| Dec 2024 | 49.66% | - | 0.28% | - | 50.34% |
| Sep 2024 | 49.66% | - | 0.28% | - | 50.34% |